EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review

Paprika Berry, Pedro H Gazzinelli-Guimaraes iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013587 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Paprika Berry und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, U…. Hauptthemen laut MEDLINE: Praziquantel, Schistosomiasis, Anthelmintics. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schistosomiasis is a neglected tropical disease targeted for elimination as a public health problem by 2030 under the WHO’s roadmap. Praziquantel, administered via the dose pole, which estimates the number of tablets needed for treatment according to an individual’s height, has been used as preventive chemotherapy (PC) for 25 years, particularly for school-aged children (SAC). In 2022, PC was required for schistosomiasis in 50 countries, affecting a total of 264.3 million people, including 129.4 million adults. This systematic review evaluates the accuracy of the praziquantel dose pole across 64,212 individuals from 21 countries, focusing on its efficacy in delivering optimal, acceptable, insufficient, and excessive doses during school-based and community-wide treatment campaigns for schistosomiasis. The search strategy included the terms “dose pole” OR “tablet pole” AND “praziquantel” AND “schistosomiasis” in four databases (PubMed, Scopus, LILACS, and Embase), ranging from 1999 to September 2024. The dose pole demonstrated 96% accuracy in providing optimal/acceptable doses (30–60mg/Kg) to SAC. However, its effectiveness markedly declined for adults (15–95 years), with a pooled proportion of 19% receiving insufficient doses (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PraziquantelSchistosomiasisAnthelminticsHumansChildAdolescentAdultTreatment OutcomeYoung Adult

Substanzen

PraziquantelAnthelmintics

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, United States of America.

ORCID-Profile: Pedro H Gazzinelli-Guimaraes

Zitieren

APA

Berry, P., & Gazzinelli-Guimaraes, P. H. (2025). Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013587

Vancouver

Berry P, Gazzinelli-Guimaraes PH. Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013587

BibTeX
@article{Berry2025,
  author = {Berry, Paprika and Gazzinelli-Guimaraes, Pedro H},
  title = {Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013587}
}
Kostenlos starten →